Strong Revenue Growth
Forian's first quarter revenue was $7.1 million, representing a 45% year-over-year growth. This growth was driven by key new pharma projects and health services renewals, as well as the full first quarter integration of Kyber Data Sciences.
Kyber Acquisition Impact
The acquisition of Kyber Data Sciences significantly contributed to revenue growth, adding approximately $1.7 million, or 35%, to the quarter's revenue. Kyber's real-world healthcare insights and analytics provide unique value to investors.
Positive Revenue Outlook for 2025
Forian projects full-year 2025 revenue to be $28 million to $30 million, representing a 39% to 49% growth year-over-year. This is a significant improvement from the previous year.
Committed Contracted Backlog
Forian has approximately $34 million of committed contracted backlog, which includes unearned revenue and unbilled amounts to be recognized as future revenue.